<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.109303</article-id><article-id pub-id-type="publisher-id">ACM-37693</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200900000_18162057.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  妊娠滋养细胞疾病血液中预测指标的研究进展
  Advances in Blood Predictors of Gestational Trophoblast Disease
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>小霞</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>亚利</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>红霞</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>延安大学，陕西 延安</addr-line></aff><aff id="aff3"><addr-line>延安大学附属医院，陕西 延安</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>09</month><year>2020</year></pub-date><volume>10</volume><issue>09</issue><fpage>2024</fpage><lpage>2028</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    妊娠滋养细胞疾病是一组来源于胎盘滋养细胞的疾病，表现为胎盘滋养细胞的异常增生。其发生是多因素参与的过程，目前对其发病机制尚不明确。其血液中的预测指标对其有重要指导意义，故该文将对血清学和炎性指标与妊娠滋养细胞疾病的关系及其可能的作用机制予以综述，以便为该疾病的发生发展提供理论依据。
    Gestational trophoblast disease is a group of diseases derived from placental trophoblast cells, which is characterized by abnormal proliferation of placental trophoblast cells. Its occurrence is a process involving multiple factors and its pathogenesis is not clear at present. Therefore, the relationship between serological and inflammatory markers and gestational trophoblast disease and its possible mechanism of action will be reviewed in this paper, so as to provide a theoretical basis for the occurrence and development of this disease. 
  
 
</p></abstract><kwd-group><kwd>妊娠滋养细胞疾病，CXC趋化因子配体10，中性粒细胞与淋巴细胞比值，红细胞分布宽度, Gestation Trophoblast Disease</kwd><kwd> CXC Chemokine Ligand 10</kwd><kwd> Neutrophil to Lymphocyte Ratio</kwd><kwd> Erythrocyte Distribution Width</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>妊娠滋养细胞疾病是一组来源于胎盘滋养细胞的疾病，表现为胎盘滋养细胞的异常增生。其发生是多因素参与的过程，目前对其发病机制尚不明确。其血液中的预测指标对其有重要指导意义，故该文将对血清学和炎性指标与妊娠滋养细胞疾病的关系及其可能的作用机制予以综述，以便为该疾病的发生发展提供理论依据。</p></sec><sec id="s2"><title>关键词</title><p>妊娠滋养细胞疾病，CXC趋化因子配体10，中性粒细胞与淋巴细胞比值，红细胞分布宽度</p></sec><sec id="s3"><title>Advances in Blood Predictors of Gestational Trophoblast Disease</title><p>Xiaoxia Wang<sup>1</sup>, Yali Liu<sup>1</sup>, Hongxia Li<sup>2*</sup></p><p><sup>1</sup>Yan’an University, Yan’an Shaanxi</p><p><sup>2</sup>Affiliated Hospital of Yan’an University, Yan’an Shaanxi</p><p><img src="//html.hanspub.org/file/23-1571566x5_hanspub.png" /></p><p>Received: Aug. 27<sup>th</sup>, 2020; accepted: Sep. 11<sup>th</sup>, 2020; published: Sep. 18<sup>th</sup>, 2020</p><p><img src="//html.hanspub.org/file/23-1571566x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Gestational trophoblast disease is a group of diseases derived from placental trophoblast cells, which is characterized by abnormal proliferation of placental trophoblast cells. Its occurrence is a process involving multiple factors and its pathogenesis is not clear at present. Therefore, the relationship between serological and inflammatory markers and gestational trophoblast disease and its possible mechanism of action will be reviewed in this paper, so as to provide a theoretical basis for the occurrence and development of this disease.</p><p>Keywords:Gestation Trophoblast Disease, CXC Chemokine Ligand 10, Neutrophil to Lymphocyte Ratio, Erythrocyte Distribution Width</p><disp-formula id="hanspub.37693-formula11"><graphic xlink:href="//html.hanspub.org/file/23-1571566x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/23-1571566x8_hanspub.png" /> <img src="//html.hanspub.org/file/23-1571566x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>妊娠滋养细胞疾病(Gestational trophoblastic disease, GTD)是一组与妊娠相关的起源于胎盘滋养细胞的增生性疾病。其在组织学上的分类为：妊娠滋养细胞肿瘤(Gestational trophoblastic neoplasia, GTN)：包括绒毛膜癌、胎盘部位滋养细胞肿瘤和上皮样滋养细胞肿瘤。葡萄胎妊娠包括完全性葡萄胎、部分性葡萄胎和侵蚀性葡萄胎，非肿瘤病变以及异常(非葡萄胎)绒毛病变四类。</p><p>葡萄胎是妊娠滋养细胞疾病中最常见的一种良性病变，大多数可经清宫后治愈，但部分会发生恶变，约有15%的完全性葡萄胎与4%的部分性葡萄胎会恶变为侵蚀性葡萄胎或绒癌 [<xref ref-type="bibr" rid="hanspub.37693-ref1">1</xref>]，因其恶变后对妇女的生殖健康有严重的影响，故临床上需要早期的预测指标以对其进行早期干预。胎盘生长因子(Placental growth factor, PLGF)、转化生长因子β1 (Transforming growth factorβ1, TGF-β1)、黏附分子CD44v6和炎性免疫因子，基因金属蛋白酶等，以及CXC趋化因子配体10 (CXC chemokine ligand-10, CXCL-10)、中性粒细胞与淋巴细胞比值(neutrophil-tolymphocyte ratio, NLR)、红细胞分布宽度(Red Cell Distribution Width，RDW)参与了多种肿瘤与妇科疾病的发生发展，但CXCL-10、NLR和RDW近年来在妊娠滋养细胞疾病方面的相关研究相对少，因此，本文对以上几项指标予以综述，以期对GTD的疾病进展提供理论依据。</p></sec><sec id="s6"><title>2. CXCL-10</title><p>CXCL-10属于趋化因子超家族中的一种，又被称为干扰素诱导蛋白。因具有炎性趋化作用，通常称为炎症趋化因子。它还具有抑制血管的作用，也称为抗血管生成趋化因子。其首次发现是Luster等 [<xref ref-type="bibr" rid="hanspub.37693-ref2">2</xref>] 在研究干扰素诱导的免疫应答反应过程中从细胞中克隆得到的，因其结构和趋化因子相类似，故将其归类于此家族。CXCL-10由单核细胞、内皮细胞和成纤维细胞分泌产生 [<xref ref-type="bibr" rid="hanspub.37693-ref3">3</xref>]，其对肿瘤具有双重作用，即抑制作用和促进作用，这与其自身的结构有关。它对肿瘤细胞的作用主要体现在促进免疫细胞的趋化及肿瘤细胞的凋亡，抑制免应答，抑制血管的作用，抑制新生血管形成和新血管形成 [<xref ref-type="bibr" rid="hanspub.37693-ref4">4</xref>] 等方面。此外CXCL-10在多种肿瘤的发生、发展过程、治疗效果和预后方面都有着重要的作用 [<xref ref-type="bibr" rid="hanspub.37693-ref5">5</xref>]。CXCL-10作为一种趋化因子具有多种作用，对滋养细胞的侵袭、浸润和转移等方面进行着重要的调控作用。研究显示：CXCL-10参与了子痫前期的发生。熊琼英、孔祥等 [<xref ref-type="bibr" rid="hanspub.37693-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref8">8</xref>] 研究结果显示：通过原位杂交法、免疫组化方法及酶联免疫吸附法(ELISA)，在一定变量情况下，CXCL-10在正常妊娠组和子痫前期患者的胎盘组织妊娠滋养细胞浆中均有表达，且CXCL-10在子痫前期患者胎盘组织中的阳性表达高于正常妊娠组，因其定位于妊娠滋养细胞的胞浆中，提示其对妊娠滋养细胞疾病有一定的作用。血清CXCL10升高可能与妊娠本身有关，因妊娠状态可引起免疫反应的改变和炎症状态的变化，CXCL10可能在子痫前期的发生发展中作为桥梁而发挥作用。研究显示：CXCL10在早孕蜕膜以及绒毛组织中的母–胎免疫平衡发挥着调节作用 [<xref ref-type="bibr" rid="hanspub.37693-ref9">9</xref>]。辛礼辉、方丽 [<xref ref-type="bibr" rid="hanspub.37693-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref11">11</xref>] 等的研究结果显示：通过免疫组织化学法检测CXCL-10在早孕绒毛、葡萄胎、葡萄胎恶变以及滋养细胞肿瘤中表达情况呈逐渐上升的趋势，且在滋养细胞肿瘤中的表达，年龄 ≥ 40岁以及临床分期为晚期(III, IV)的表达均高于年龄 &lt; 40岁及分期(I, II)。CXCL-10参与妊娠滋养细胞疾病的发生发展可能有以下机制：①通过改变微环境，打破了母–胎间的免疫平衡，使绒毛组织对母体产生过度侵袭，从而来增加滋养细胞疾病的浸润能力。②CXCL10激活后引起循环中炎性细胞如单核细胞、嗜中性粒细胞和炎症介质的激活与释放，最终导致机体内免疫平衡的失调。③CXCL10可以通过自分泌形式来促进妊娠滋养细胞的生长、浸润和转移 [<xref ref-type="bibr" rid="hanspub.37693-ref12">12</xref>]。</p></sec><sec id="s7"><title>3. 中性粒细胞与淋巴细胞比值(NLR)</title><p>NLR是反映全身炎症的一项指标，因其操作简单易得，又能反应机体内的炎性变化，所以其在近年来研究逐渐增加。一开始是被用来评估重症患者和创伤患者的情况，后来被应用到肿瘤领域，发现其与乳腺癌、胃癌、结肠癌等的预后相关 [<xref ref-type="bibr" rid="hanspub.37693-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref14">14</xref>]。Abu-Shawer O.等 [<xref ref-type="bibr" rid="hanspub.37693-ref15">15</xref>] 研究显示：在妇科实体肿瘤(包括宫颈癌、子宫内膜癌、卵巢癌等)中，有高NLR表达水平的肿瘤，其远处转移率较低基线NLR高，预后较差。但其导致预后差的机制尚不清楚，可能与中性粒细胞释放某些物质，如生长因子和其他蛋白酶等，进一步促进肿瘤细胞的侵袭和转移等。淋巴细胞计数值高被认为是一个良好的预后指标，NLR比值高，代表淋巴细胞数量少，可能是诱导了细胞发生死亡，从而进一步阻碍肿瘤细胞的增殖和转移作用，降低免疫反应 [<xref ref-type="bibr" rid="hanspub.37693-ref16">16</xref>]。NLR可作为产后糖尿病发生的预测指标 [<xref ref-type="bibr" rid="hanspub.37693-ref17">17</xref>]，NLR也可以反应子痫前期的严重程度，可尽早对疾病预测做出较好的评估，尽快改善妊娠结局 [<xref ref-type="bibr" rid="hanspub.37693-ref18">18</xref>]。而NLR作为妊娠滋养细胞疾病的预测指标在国内研究较少，Guzel A. [<xref ref-type="bibr" rid="hanspub.37693-ref19">19</xref>] 首次将NLR作为妊娠滋养细胞疾病预后的预测指标，研究显示：在侵蚀性葡萄胎患者中NLR水平高于葡萄胎患者，可认为NLR增加了妊娠滋养细胞的侵袭性。陈雨薇、刘睿等 [<xref ref-type="bibr" rid="hanspub.37693-ref20">20</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref21">21</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref22">22</xref>] 研究结果显示：通过回顾性分析，发现清宫前葡萄胎恶变组中NLR明显高于非恶变组，NLR是葡萄胎恶变的独立危险因素。NLR可能通过以下机制发挥作用：①中性粒细胞通过促进血管生成，提供适合肿瘤生长的环境，从而导致更多的肿瘤生长和侵袭 [<xref ref-type="bibr" rid="hanspub.37693-ref23">23</xref>]。②中性粒细胞通过释放氧自由基等来抑制机体免疫功能，尤其是T淋巴细胞的作用，导致抗肿瘤免疫能力降低 [<xref ref-type="bibr" rid="hanspub.37693-ref24">24</xref>]。③淋巴细胞在肿瘤的免疫方面发挥着重要的作用，淋巴细胞细胞减少，形成了利于妊娠滋养细胞增生及侵袭的环境，导致恶变的风险加大，预后不良。</p></sec><sec id="s8"><title>4. 红细胞分布宽度(RDW)</title><p>RDW是循环红细胞大小变化的指标之一 [<xref ref-type="bibr" rid="hanspub.37693-ref25">25</xref>]，在既往研究中主要用于贫血相关疾病的诊断和治疗，但是近几年国内外对其研究有了诸多新发现，其可作为多种疾病的预测指标，比如系统性红斑狼疮(systemic lupus erythematosus, SLE)、类风湿性关节炎等自身免疫系统疾病，有研究显示其主要是影响红细胞的沉降率来发挥作用，以及与超敏C反应蛋白也有相关 [<xref ref-type="bibr" rid="hanspub.37693-ref26">26</xref>]，以及在心血管，肾脏疾病方面的研究 [<xref ref-type="bibr" rid="hanspub.37693-ref27">27</xref>]。并赋予其新的临床意义，认为其可以用来作为反应全身炎症的一项指标。其逐渐在妊娠及肿瘤学方面有了新进展。王慧、朱姣等人 [<xref ref-type="bibr" rid="hanspub.37693-ref28">28</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref29">29</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref30">30</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref31">31</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref32">32</xref>] 分析其在妊娠期高血压疾病中的作用，研究显示：通过回顾性分析，以及病例对照等分析发现RDW在子痫前期的患者孕妇中明显升高，且随着RDW值的升高，其严重程度及不良预后的结局增加。因为其更廉价及简便，可将其作为诊断和分级的参考指标。高飞、王爽等 [<xref ref-type="bibr" rid="hanspub.37693-ref33">33</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref34">34</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref35">35</xref>] 研究发现：RDW在妊娠期糖尿病患者中水平高于正常妊娠组，提示RDW参与妊娠期糖尿病的发生。研究表明，RDW的高水平还参与妇科恶性肿瘤(子宫内膜癌、卵巢癌及宫颈癌) [<xref ref-type="bibr" rid="hanspub.37693-ref36">36</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref37">37</xref>] [<xref ref-type="bibr" rid="hanspub.37693-ref38">38</xref>] 有关。而其在妊娠滋养细胞疾病中的作用国内文献较少，Zhang L.研究 [<xref ref-type="bibr" rid="hanspub.37693-ref39">39</xref>] 显示：通过回顾性分析，侵蚀性葡萄胎组102例，对照组120例。结果发现RDW在侵蚀性葡萄胎组(0.16)中的表达明显高于对照组(0.13)的水平，(p &lt; 0.05)。经过病理检查后，进行Grade分级，54例为I和II级，48例III和IV级。结果显示III和IV级(0.15)的侵蚀性葡萄胎患者的RDW水平高于I和II级别(0.13)的患者(p &lt; 0.05)。相关性显示其与侵蚀性葡萄胎不同分期呈正相关。因此推测RDW参与妊娠滋养细胞的过程可能为RDW通过反应内皮损伤及体内炎性反应，同炎性因子作用相似，来介导肿瘤的发生、侵袭和转移。其具体机制有待进一步研究，但为妊娠滋养细胞疾病的预后提供新了的思路。</p></sec><sec id="s9"><title>5. 展望</title><p>综上所述，CXCL-10、NLR、RDW都与妊娠滋养细胞疾病的发生发展有一定的关系，因此可通过对血中预测因子的检测，确定GTD的恶变相关指标，为妊娠滋养细胞早期预测提供理论依据，提高对GTD患者的早诊断及早治疗，从而降低恶变率，改善患者的预后。</p></sec><sec id="s10"><title>文章引用</title><p>王小霞,刘亚利,李红霞. 妊娠滋养细胞疾病血液中预测指标的研究进展Advances in Blood Predictors of Gestational Trophoblast Disease[J]. 临床医学进展, 2020, 10(09): 2024-2028. https://doi.org/10.12677/ACM.2020.109303</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.37693-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">向阳, 周琦, 吴小华, 刘继红, 李力, 朱笕青, 白萍, 盛修贵. 妊娠滋养细胞疾病诊断与治疗指南(第四版)[J]. 中国实用妇科与产科杂志, 2018, 34(9): 994-1001.</mixed-citation></ref><ref id="hanspub.37693-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Shao, R., Cao, Q.J., Arenas, R.B., Bigelow, C., Bentley, B. and Yan, W. (2011) Breast Cancer Expression of YKL-40 Correlates with Tuomor Grade, Poor Differentiation, Andother Cancer Markers. British Journal of Cancer, 105, 1203-1209.  
&lt;br&gt;https://doi.org/10.1038/bjc.2011.347</mixed-citation></ref><ref id="hanspub.37693-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Li, L.X., Xia, Y.T., Sun, X.Y., et al. (2020) CXCL-10/CXCR3 in Macrophages Regulates Tissue Repair by Controlling the Expression of Arg1, VEGFa and TNFα. Journal of Biological Regulators &amp; Homeostatic Agents, 34, 987-999.</mixed-citation></ref><ref id="hanspub.37693-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Karimabad, M.N. and Hassanshahi, G. (2015) Significance of CXCL12 in Type 2 Diabetes Mellitus and Its Associated Complications. Inflammation, 38, 710-717. &lt;br&gt;https://doi.org/10.1007/s10753-014-9981-3</mixed-citation></ref><ref id="hanspub.37693-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">许锦辉, 杨玲麟, 杨金平, 等. 趋化因子 CXCL10 在恶性肿瘤发生、发展的研究进展[J]. 重庆医学, 2016, 45(13): 1849-1851.</mixed-citation></ref><ref id="hanspub.37693-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">熊琼英, 张芳华. 重度子痫前期孕妇血清CXCL10、心肝肾功能指标及妊娠结局分析[J]. 中国妇幼保健, 2015, 30(33): 5777-5779.</mixed-citation></ref><ref id="hanspub.37693-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">孔祥, 郑英, 卢丹, 赵群, 王志学. 子痫前期患者血清YKL-40、CXCL10变化及意义[J]. 江苏医药, 2014, 40(22): 2784-2786.</mixed-citation></ref><ref id="hanspub.37693-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">郭学敏. CXCL10在子痫前期患者胎盘组织中的表达及意义[D]: [硕士研究论文]. 太原: 山西医科大学, 2014.</mixed-citation></ref><ref id="hanspub.37693-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">白晓霞, 孔北华, 张友忠, 等. 早孕蜕膜及绒毛组织中趋化因子CXC受体3、4及其配体的表达变化及意义[J]. 中华妇产科杂志, 2008, 12(43): 904-908.</mixed-citation></ref><ref id="hanspub.37693-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">辛礼辉, 贾小娜, 郭晓娟, 冯小伟. CXCL10和MMP-13在妊娠滋养细胞疾病滋养细胞中的表达及其临床意义[J]. 中国组织化学与细胞化学杂志, 2019, 28(2): 150-155.</mixed-citation></ref><ref id="hanspub.37693-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">辛礼辉, 方丽, 袁艳龙, 冯小伟, 郭晓娟, 张小辉, 贾小娜, 惠京. YKL-40和CXCL10在妊娠滋养细胞疾病中的表达及临床意义[J]. 热带医学杂志, 2019, 19(3): 313-315+328.</mixed-citation></ref><ref id="hanspub.37693-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Wightman, S.C., Uppal, A., Pitroda, S.P., et al. (2015) Oncogenic CXCL10 Signalling Drives Metastasis Development and Poor Clinical Outcome. British Journal of Cancer, 113, 327-335. &lt;br&gt;https://doi.org/10.1038/bjc.2015.193</mixed-citation></ref><ref id="hanspub.37693-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Abu-Shawer, O., Abu-Shawer, M., Haimour, A., et al. (2019) Hematologic Markers of Distant Metastases in Gastric Cancer. Journal of Gastrointestinal Oncology, 10, 529-536. &lt;br&gt;https://doi.org/10.21037/jgo.2019.01.12</mixed-citation></ref><ref id="hanspub.37693-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Nagasaki, T., Akiyoshi, T., Fujimoto, Y., Konishi, T., Nagayama, S., Fukunaga, Y. and Ueno, M. (2015) Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy. Digestive Surgeryrg, 32, 496-503. &lt;br&gt;https://doi.org/10.1159/000441396</mixed-citation></ref><ref id="hanspub.37693-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Abu-Shawer, O., Abu-Shawer, M., Hirmas, N., et al. (2019) Hematologic Markers of Distant Metastases and Poor Prognosis in Gynecological Cancers. BMC Cancer, 19, Article No. 141. &lt;br&gt;https://doi.org/10.1186/s12885-019-5326-9</mixed-citation></ref><ref id="hanspub.37693-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Swann, J.B. and Smyth, M.J. (2007) Immune Surveillance of Tumors. Journal of Clinical Investigation, 117, 1137-1146.  
&lt;br&gt;https://doi.org/10.1172/JCI31405</mixed-citation></ref><ref id="hanspub.37693-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">符玲玲, 李莉, 陈昌明, 刘振燕. DM患者孕晚期外周血中性粒细胞/淋巴细胞比值、红细胞分布宽度的检测意义分析[J]. 中国医学创新, 2020, 17(17): 28-32.</mixed-citation></ref><ref id="hanspub.37693-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">尹学敬, 杨占辉. 外周血中炎性指标及血小板分布宽度与子痫前期的相关性研究[J]. 河北医药, 2019, 41(19): 2918-2921.</mixed-citation></ref><ref id="hanspub.37693-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Irfan, G.A., Kuntay, K.M., Selcuk, E., et al. (2014) Predictive Role of the Neutrophil Lymphocyte Ratio for Invasion with Gestational Trophoblastic Disease. Asian Pacific Journal of Cancer Prevention, 15, 4203-4206.  
&lt;br&gt;https://doi.org/10.7314/APJCP.2014.15.10.4203</mixed-citation></ref><ref id="hanspub.37693-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">刘睿, 张涛红, 胡娇娇, 安瑞芳. 外周血系统性炎症标志物预测完全性葡萄胎恶变的价值研究[J]. 实用妇产科杂志, 2020, 36(1): 31-36.</mixed-citation></ref><ref id="hanspub.37693-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">张素素, 邵军晖, 张六连. 中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值、β人绒毛膜促性腺激素和宫腔团块最大直径对葡萄胎预后的预测价值[J]. 广西医学, 2019, 41(22): 2875-2878.</mixed-citation></ref><ref id="hanspub.37693-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">陈雨薇, 张虹. 清宫前中性粒细胞-淋巴细胞比值对葡萄胎恶变的预测价值[J]. 实用妇产科杂志, 2016, 32(4): 294-297.</mixed-citation></ref><ref id="hanspub.37693-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Kim, Y.-J., Lee, I., Chung, Y. S., et al. (2018) Pretreatment Neutrophil-to-Lymphocyte Ratio and Its Dynamic Change during Neoadjuvant Chemotherapy as Poor Prognostic Factors in Advanced Ovarian Cancer. Obstetrics &amp; Gynecology Science, 61, 227-234. &lt;br&gt;https://doi.org/10.5468/ogs.2018.61.2.227</mixed-citation></ref><ref id="hanspub.37693-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Son, S.M., Hwang, E.C., Jung, S.I, et al. (2018) Prognostic Value of Preoperative Systemic Inflammation Markers in Localized Upper Tract Urothelial Cell Carcinoma: A Large, Multicenter Cohort Analysis. Minerva Urologica e Nefrologica, 70, 300-309.</mixed-citation></ref><ref id="hanspub.37693-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Goyal, H. and Hu, Z.D. (2017) Prognostic Value of Red Blood Cell Distribution Width in Hepatocellular Carcinoma. Annals of Translational Medicine, 5, 271. &lt;br&gt;https://doi.org/10.21037/atm.2017.06.30</mixed-citation></ref><ref id="hanspub.37693-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">聂爱若, 宫变荣. 妊娠高血压疾病与妊娠糖尿病孕妇凝血功能与血脂检测意义[J]. 临床医学研究与实践, 2017, 2(31): 88-89.</mixed-citation></ref><ref id="hanspub.37693-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">叶鉴南, 孙超, 李建勇, 周新. 红细胞分布宽度在肿瘤中的预后价值[J]. 国际肿瘤学杂志, 2019(8): 485-488.</mixed-citation></ref><ref id="hanspub.37693-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">王慧, 周容. 红细胞分布宽度与子痫前期关系的研究进展[J]. 实用妇产科杂志, 2020, 36(7): 507-509.</mixed-citation></ref><ref id="hanspub.37693-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">朱姣. 红细胞分布宽度在子痫前期孕妇的妊娠结局中的预测价值[J]. 齐齐哈尔医学院学报, 2018, 39(18): 2139-2140.</mixed-citation></ref><ref id="hanspub.37693-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">傅钰. 血小板与淋巴细胞比值、红细胞分布宽度预测孕妇子痫前期严重程度的临床意义[D]: [硕士研究论文]. 延吉: 延边大学, 2018.</mixed-citation></ref><ref id="hanspub.37693-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">吴慧娟. NLR、PLR、RDW、MPV及PCT预测子痫前期的临床意义[D]: [硕士研究论文]. 南昌: 南昌大学, 2018.</mixed-citation></ref><ref id="hanspub.37693-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">龚丹, 付广红, 刘芳. 红细胞分布宽度在妊娠高血压综合征患者中的变化及临床意义[J]. 当代医学, 2018, 24(7): 144-146.</mixed-citation></ref><ref id="hanspub.37693-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">王爽. 妊娠期糖尿病患者红细胞分布宽度及中性粒细胞/淋巴细胞比值的分析[J]. 中国医药指南, 2019, 17(24): 97.</mixed-citation></ref><ref id="hanspub.37693-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">高飞, 郑浩, 邱先桃, 陈小娟, 王洁琳, 龙燕, 高秀蓉. 妊娠期糖尿病患者红细胞分布宽度及中性粒细胞/淋巴细胞比值分析[J]. 国际检验医学杂志, 2017, 38(6): 774-776.</mixed-citation></ref><ref id="hanspub.37693-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">高飞, 杨红玲, 王洁琳, 高秀蓉, 龙燕, 郑浩, 陈小娟. 妊娠期糖尿病患者红细胞分布宽度与胰岛素抵抗的相关性研究[J]. 现代检验医学杂志, 2017, 32(1): 66-68.</mixed-citation></ref><ref id="hanspub.37693-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Kose, M., Celik, F., Kose, S.K., Arioz, D.T. and Yilmazer, M. (2015) Could the Platelet-to-Lymphocyte Ratio Be a Novel Marker for Predicting Invasiveness of Cervical Pathologies? Asian Pacific Journal of Cancer Prevention, 16, 923-926. &lt;br&gt;https://doi.org/10.7314/APJCP.2015.16.3.923</mixed-citation></ref><ref id="hanspub.37693-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Li, Z., Hong, N., Robertson, M., Wang, C. and Jiang, G.Q. (2017) Preoperative Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio Predict Survival in Patients with Epithelial Ovarian Cancer. Scientific Reports, 7, Article No. 43001. &lt;br&gt;https://doi.org/10.1038/srep43001</mixed-citation></ref><ref id="hanspub.37693-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Kemal, Y., Demirag, G., Baş, B., Önem, S., Teker, F. and Yücel, I. (2015) The Value of Red Blood Cell Distribution Width in Endometrial Cancer. Clinical Chemistry and Laboratory Medicine, 53, 823-827.  
&lt;br&gt;https://doi.org/10.1515/cclm-2014-0699</mixed-citation></ref><ref id="hanspub.37693-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., Xie, Y. and Zhan, L. (2019) The Potential Value of Red Blood Cell Distribution Width in Patients with Invasive Hydatidiform Mole. Journal of Clinical Laboratory Analysis, 33, e22846.  
&lt;br&gt;https://doi.org/10.1002/jcla.22846</mixed-citation></ref></ref-list></back></article>